Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

AbstractInfection of cells by vesicular stomatitis virus (VSV) results in the inhibition of host transcription. We show in this study that infection of HeLa cells with VSV leads to a strongly diminished activation of STAT3 and STAT1 by the inflammatory cytokine IL-6. This effect was mimicked by forced expression of a single viral protein, the matrix (M)-protein of VSV, which blocked STAT activation via chimeric receptors containing the cytoplasmic domain of the IL-6 signal transducer gp130. Western blot analysis revealed that VSV M-protein did not inhibit the nuclear translocation of activated STAT3 but did inhibit its tyrosine phosphorylation. Inhibition of STAT activation was not dependent on tyrosine 759 of the IL-6 signal transducer gp130, suggesting that the inhibitory action of VSV M-protein is not mediated by the induction of the suppressor of cytokine signaling 3. VSV M-protein inhibited gene transcription from cotransfected α2-macroglobulin or antichymotrypsin promoter/luciferase reporter constructs which contain STAT3-binding sites. However, transcription from a STAT5-dependent construct was not negatively affected. In conclusion, our data suggest that infection by VSV and specifically overexpression of the viral M-protein interferes with an important signaling pathway necessary for triggering antiviral and inflammatory responses.

Bibliography

Terstegen, L., Gatsios, P., Ludwig, S., Pleschka, S., Jahnen-Dechent, W., Heinrich, P. C., & Graeve, L. (2001). The Vesicular Stomatitis Virus Matrix Protein Inhibits Glycoprotein 130-Dependent STAT Activation. The Journal of Immunology, 167(9), 5209–5216.

Authors 7
  1. Lara Terstegen (first)
  2. Petros Gatsios (additional)
  3. Stephan Ludwig (additional)
  4. Stephan Pleschka (additional)
  5. Willi Jahnen-Dechent (additional)
  6. Peter C. Heinrich (additional)
  7. Lutz Graeve (additional)
References 49 Referenced 13
  1. Heinrich, P. C., I. Behrmann, G. Müller-Newen, F. Schaper, L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334: 297 (10.1042/bj3340297)
  2. Pellegrini, S., I. Dusanter-Fourt. 1997. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248: 615 (10.1111/j.1432-1033.1997.00615.x)
  3. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277: 1630 (10.1126/science.277.5332.1630)
  4. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr, G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349 (10.1126/science.7871433)
  5. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5: 449 (10.1016/S1074-7613(00)80501-4)
  6. Schaper, F., C. Gendo, M. Eck, J. Schmitz, C. Grimm, D. Anhuf, I. M. Kerr, P. C. Heinrich. 1998. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Biochem. J. 335: 557 (10.1042/bj3350557)
  7. Symes, A., N. Stahl, S. A. Reeves, T. Farruggella, T. Servidei, T. Gearan, G. Yancopoulos, J. S. Fink. 1997. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr. Biol. 7: 697 (10.1016/S0960-9822(06)00298-3)
  8. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387: 917 (10.1038/43206)
  9. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, et al 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924 (10.1038/43219)
  10. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921 (10.1038/43213)
  11. Terstegen, L., P. Gatsios, J. G. Bode, F. Schaper, P. C. Heinrich, L. Graeve. 2000. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine-759 in the cytoplasmic tail of gp130. J. Biol. Chem. 275: 18810 (10.1074/jbc.M904148199)
  12. Schmitz, J., M. Weissenbach, S. Haan, P. C. Heinrich, F. Schaper. 2000. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J. Biol. Chem. 275: 12848 (10.1074/jbc.275.17.12848)
  13. Nicholson, S. E., D. De Souza, L. J. Fabri, J. Corbin, T. A. Willson, J. G. Zhang, A. Silva, M. Asimakis, A. Farley, A. D. Nash, et al 2000. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. USA 97: 6493 (10.1073/pnas.100135197)
  14. Stoiber, D., P. Kovarik, S. Cohney, J. A. Johnston, P. Steinlein, T. Decker. 1999. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ. J. Immunol. 163: 2640 (10.4049/jimmunol.163.5.2640)
  15. Bode, J. G., A. Nimmesgern, J. Schmitz, F. Schaper, M. Schmitt, W. Frisch, D. Häussinger, P. C. Heinrich, L. Graeve. 1999. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 463: 365 (10.1016/S0014-5793(99)01662-2)
  16. Grinnell, B. W., R. R. Wagner. 1984. Nucleotide sequence and secondary structure of VSV leader RNA and homologous DNA involved in inhibition of DNA-dependent transcription. Cell 36: 533 (10.1016/0092-8674(84)90246-0)
  17. Weck, P. K., R. R. Wagner. 1979. Vesicular stomatitis virus infection reduces the number of active DNA-dependent RNA polymerases in myeloma cells. J. Biol. Chem. 254: 5430 (10.1016/S0021-9258(18)50614-1)
  18. Black, B. L., D. S. Lyles. 1992. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66: 4058 (10.1128/jvi.66.7.4058-4064.1992)
  19. Paik, S. Y., A. C. Banerjea, G. G. Harmison, C. J. Chen, M. Schubert. 1995. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J. Virol. 69: 3529 (10.1128/jvi.69.6.3529-3537.1995)
  20. Ferran, M. C., J. M. Lucas-Lenard. 1997. The vesicular stomatitis virus matrix protein inhibits transcription from the human β-interferon promoter. J. Virol. 71: 371 (10.1128/jvi.71.1.371-377.1997)
  21. Ahmed, M., D. S. Lyles. 1998. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J. Virol. 72: 8413 (10.1128/JVI.72.10.8413-8419.1998)
  22. Her, L. S., E. Lund, J. E. Dahlberg. 1997. Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276: 1845 (10.1126/science.276.5320.1845)
  23. Petersen, J. M., L. S. Her, V. Varvel, E. Lund, J. E. Dahlberg. 2000. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol. Cell. Biol. 20: 8590 (10.1128/MCB.20.22.8590-8601.2000)
  24. von Kobbe, C., J. M. van Deursen, J. P. Rodrigues, D. Sitterlin, A. Bachi, X. Wu, M. Wilm, M. Carmo-Fonseca, E. Izaurralde. 2000. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin nup98. Mol. Cell. 6: 1243 (10.1016/S1097-2765(00)00120-9)
  25. Petersen, J. M., L. S. Her, J. E. Dahlberg. 2001. Multiple vesiculoviral matrix proteins inhibit both nuclear export and import. Proc. Natl. Acad. Sci. USA 98: 8590 (10.1073/pnas.151240998)
  26. Sasse, J., U. Hemmann, C. Schwartz, U. Schniertshauer, B. Heesel, C. Landgraf, J. Schneider-Mergener, P. C. Heinrich, F. Horn. 1997. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol. Cell. Biol. 17: 4677 (10.1128/MCB.17.8.4677)
  27. Gerhartz, C., B. Heesel, J. Sasse, U. Hemmann, C. Landgraf, J. Schneider-Mergener, F. Horn, P. C. Heinrich, L. Graeve. 1996. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J. Biol. Chem. 271: 12991 (10.1074/jbc.271.22.12991)
  28. Kordula, T., R. E. Rydel, E. F. Brigham, F. Horn, P. C. Heinrich, J. Travis. 1998. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate α1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273: 4112 (10.1074/jbc.273.7.4112)
  29. Coqueret, O., H. Gascan. 2000. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275: 18794 (10.1074/jbc.M001601200)
  30. Flory, E., M. Kunz, C. Scheller, C. Jassoy, R. Stauber, U. R. Rapp, S. Ludwig. 2000. Influenza virus-induced NF-κB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IκB kinase. J. Biol. Chem. 275: 8307 (10.1074/jbc.275.12.8307)
  31. Andrews, N. C., D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19: 2499 (10.1093/nar/19.9.2499)
  32. Wagner, B. J., T. E. Hayes, C. J. Hoban, B. H. Cochran. 1990. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9: 4477 (10.1002/j.1460-2075.1990.tb07898.x)
  33. Wegenka, U. M., J. Buschmann, C. Lütticken, P. C. Heinrich, F. Horn. 1993. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13: 276 (10.1128/mcb.13.1.276-288.1993)
  34. Lefrancois, L., D. S. Lyles. 1982. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes. Virology 121: 168 (10.1016/0042-6822(82)90126-X)
  35. Ludwig, S., K. Engel, A. Hoffmeyer, G. Sithanandam, B. Neufeld, D. Palm, M. Gaestel, U. R. Rapp. 1996. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol. Cell. Biol. 16: 6687 (10.1128/MCB.16.12.6687)
  36. Mackiewicz, A., H. Schooltink, P. C. Heinrich, S. Rose-John. 1992. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 149: 2021 (10.4049/jimmunol.149.6.2021)
  37. Rayanade, R. J., K. Patel, M. Ndubuisi, S. Sharma, S. Omura, J. D. Etlinger, R. Pine, P. B. Sehgal. 1997. Proteasome- and p53-dependent masking of signal transducer and activator of transcription (STAT) factors. J. Biol. Chem. 272: 4659 (10.1074/jbc.272.8.4659)
  38. Kunz, D., R. Zimmermann, M. Heisig, P. C. Heinrich. 1989. Identification of the promoter sequences involved in the interleukin-6 dependent expression of the rat α2-macroglobulin gene. Nucleic Acids Res. 17: 1121 (10.1093/nar/17.3.1121)
  39. Cebulla, C. M., D. M. Miller, D. D. Sedmak. 1999. Viral inhibition of interferon signal transduction. Intervirology 42: 325 (10.1159/000053968)
  40. Heim, M. H., D. Moradpour, H. E. Blum. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73: 8469 (10.1128/JVI.73.10.8469-8475.1999)
  41. Leonard, G. T., G. C. Sen. 1996. Effects of adenovirus E1A protein on interferon-signaling. Virology 224: 25 (10.1006/viro.1996.0503)
  42. Leonard, G. T., G. C. Sen. 1997. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein. J. Virol. 71: 5095 (10.1128/jvi.71.7.5095-5101.1997)
  43. Takeda, T., K. Nakajima, H. Kojima, T. Hirano. 1994. E1A repression of IL-6-induced gene activation by blocking the assembly of IL-6 response element binding complexes. J. Immunol. 153: 4573 (10.4049/jimmunol.153.10.4573)
  44. Barnard, P., N. A. McMillan. 1999. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α. Virology 259: 305 (10.1006/viro.1999.9771)
  45. Li, S., S. Labrecque, M. C. Gauzzi, A. R. Cuddihy, A. H. Wong, S. Pellegrini, G. J. Matlashewski, A. E. Koromilas. 1999. The human papillomavirus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α. Oncogene 18: 5727 (10.1038/sj.onc.1202960)
  46. Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, J. W. Waldman, D. D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187: 675 (10.1084/jem.187.5.675)
  47. Miller, D. M., Y. Zhang, B. M. Rahill, W. J. Waldman, D. D. Sedmak. 1999. Human cytomegalovirus inhibits IFN-α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction. J. Immunol. 162: 6107 (10.4049/jimmunol.162.10.6107)
  48. Guschin, D., N. Rogers, J. Briscoe, B. Witthuhn, D. Watling, F. Horn, S. Pellegrini, K. Yasukawa, P. Heinrich, G. R. Stark, et al 1995. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14: 1421 (10.1002/j.1460-2075.1995.tb07128.x)
  49. Yuan, H., S. Puckett, D. S. Lyles. 2001. Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits. J. Virol. 75: 4453 (10.1128/JVI.75.9.4453-4458.2001)
Dates
Type When
Created 11 years, 4 months ago (April 20, 2014, 11:19 p.m.)
Deposited 8 months ago (Jan. 2, 2025, 2:04 p.m.)
Indexed 4 weeks, 1 day ago (Aug. 7, 2025, 4:34 p.m.)
Issued 23 years, 10 months ago (Nov. 1, 2001)
Published 23 years, 10 months ago (Nov. 1, 2001)
Published Print 23 years, 10 months ago (Nov. 1, 2001)
Funders 0

None

@article{Terstegen_2001, title={The Vesicular Stomatitis Virus Matrix Protein Inhibits Glycoprotein 130-Dependent STAT Activation}, volume={167}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.167.9.5209}, DOI={10.4049/jimmunol.167.9.5209}, number={9}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Terstegen, Lara and Gatsios, Petros and Ludwig, Stephan and Pleschka, Stephan and Jahnen-Dechent, Willi and Heinrich, Peter C. and Graeve, Lutz}, year={2001}, month=nov, pages={5209–5216} }